Danaher Corp (DHR) 86.81 $DHR
Rexnord Corporation Names George Moore to Its Board of Directors
Business Wire - Fri Feb 13, 8:35AM CST
Rexnord Corporation (NYSE: RXN) today announced that George C. Moore will join the Company's Board of Directors effective February 12, 2015.
RXN: 27.85 (+0.08), DHR: 86.81 (+0.21)
Danaher To Present At Barclays Industrial Select Conference
PR Newswire - Thu Feb 12, 3:45PM CST
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Barclays Industrial Select Conference in Miami, Florida on Thursday, February 19, 2015 at 8:55 a.m. ET. The audio will be simultaneously webcast and will be archived on www.danaher.com.
DHR: 86.81 (+0.21)
Leading Vaporization Company Ploom Brings on Two Senior Executives
Business Wire - Wed Feb 11, 10:00AM CST
Ploom, a San Francisco-based leader in vaporization delivery systems, announced today that it has added two senior executives to its team. Timothy Danaher was named VP of Finance and Scott Dunlap was appointed Chief Marketing Officer. Reporting to Founder and CEO James Monsees, Mr. Danaher will play a critical role in developing and executing the overall business and financial strategy of Ploom to maximize sales growth and profitability. Mr. Dunlap will be responsible for crafting the strategic marketing vision and plan behind all of Ploom's future, innovative, first-to-market products. He will also report to the CEO, James Monsees.
DHR: 86.81 (+0.21)
General Purpose Test Equipment Market in China 2015-2019 with Agilent Technologies, Anritsu, Danaher, Fluke, Rohde & Schwarz & Tektronix Dominating
M2 - Wed Feb 11, 5:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/n2w98n/general_purpose) has announced the addition of the "General Purpose Test Equipment Market in China 2015-2019" report to their offering. The analysts forecast the General Purpose Test Equipment market in China to grow at a CAGR of 9.89 percent over the period 2015-2019. This report covers the present scenario and the growth prospects of the General Purpose Test Equipment market in China during the period 2015-2019. To calculate the market size and vendor share, the report considers revenue generated from the sales of general purpose test equipment and its services in China. General purpose test equipment includes different testing and measuring equipment such as oscilloscopes, spectrum analyzers, signal generators, multimeters, arbitrary waveform generators, logic analyzers, spectrum analyzers, power meters, electronic counters, and VXI/PXI-based instruments. Industries such as Communications, Aerospace and Defense, Mechanical, and Electronics uses this equipment for testing their design prototypes or finished products to check uniformity with the required specifications and ascertain whether the devices are fulfilling their intended purpose. Key Vendors - Agilent Technologies - Anritsu - Danaher - Fluke - Rohde & Schwarz - Tektronix Other Prominent Vendors - Adlink Technology - Aeroflex - Ametek - Giga-tronics - National Instruments - Rigol Technologies - Teledyne LeCroy - Teradyne - Yokagawa Electric Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product - Market Segmentation by Technology Type - Market Segmentation by End-users - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/n2...al_purpose
AME: 51.41 (+0.80), A: 40.15 (+0.13), DHR: 86.81 (+0.21), TER: 19.43 (+0.04), NATI: 31.20 (+0.31)
Two Executives Join ediscovery Leadership Team at Disco
Business Wire - Tue Feb 10, 6:30AM CST
Legal technology company CS Disco Inc., based in Houston, Texas, has announced two executives have joined the Disco ediscovery team, including a vice president of sales and a vice president of engineering and product development.
DHR: 86.81 (+0.21)
Macrocure Hires Mark Page as Chief Financial Officer
GlobeNewswire - Mon Feb 09, 3:04AM CST
Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, today announced that Mark Page, a Managing Director at Credit Suisse in New York, will join Macrocure as Chief Financial Officer effective February 10, 2015.
JNJ: 99.62 (+1.18), MCUR: 11.19 (-0.65), DHR: 86.81 (+0.21)
Industrial Conglomerates Equities Technical Updates - General Electric, 3M, Danaher, Koninklijke Philips, and Roper Industries
PR Newswire - Fri Feb 06, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: General Electric Company (NYSE: GE), 3M Company (NYSE: MMM), Danaher Corporation (NYSE: DHR), Koninklijke Philips N.V. (NYSE: PHG), and Roper Industries Inc. (NYSE: ROP). Free research report on General Electric can be accessed at http://get.Investor-Edge.com/pdf/?c=General%2...5&s=GE. On Thursday, February 05, 2015, the NASDAQ Composite ended at 4,765.10, up 1.03%, the Dow Jones Industrial Average advanced 1.20%, to finish the day at 17,884.88, and the S&P 500 closed at 2,062.52, up 1.03%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Industrials Sector Index ended the day at 483.79, up 0.97%, with the index also advancing 1.96% in the last one month. Register for your complimentary reports at the links given below.
ROP: 166.23 (+1.16), MMM: 165.94 (+0.03), GE: 25.15 (+0.26), PHG: 28.93 (-0.07), DHR: 86.81 (+0.21)
3 Stocks Boosting The Industrial Goods Sector Higher
at The Street - Thu Feb 05, 11:03AM CST
TheStreet highlights 3 stocks pushing the industrial goods sector higher today.
HON: 104.38 (+0.88), UTX: 121.25 (+1.66), DHR: 86.81 (+0.21)
Macquarie (MIC) to Acquire Bayonne Energy for $720M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 5:11PM CST
Macquarie Infrastructure Company (MIC) recently entered into an agreement to acquire Bayonne Energy Center (BEC) for approximately $720 million.
MIC: 76.58 (+1.26), FSS: 15.75 (+0.09), DHR: 86.81 (+0.21)
GE Secures General Dynamics Orders Worth $100M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 4:08PM CST
General Electric's Intelligent Platforms, a part of General Electric Company (GE), recently secured orders worth approximately $100 million from General Dynamics UK.
GD: 137.61 (-0.54), GE: 25.15 (+0.26), FSS: 15.75 (+0.09), DHR: 86.81 (+0.21)
SmarTrend Watching for Potential Pullback in Shares of Danaher After 1.53% Gain
Comtex SmarTrend(R) - Tue Feb 03, 4:48PM CST
Danaher (NYSE
HR) traded in a range yesterday that spanned from a low of $84.27 to a high of $85.13. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $83.98 on volume of 4.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DHR: 86.81 (+0.21)
Danaher Rises 1.53% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Feb 03, 4:47PM CST
Danaher (NYSE HR) traded in a range yesterday that spanned from a low of $84.27 to a high of $85.13. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $83.98 on volume of 4.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DHR: 86.81 (+0.21)
United Technologies (UTX) Hikes Quarterly Dividend by 8.5% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 4:00PM CST
United Technologies Corporation (UTX) recently announced an 8.5% year-over-year hike in its quarterly dividend payout to 64 cents per share or $2.56 on an annualized basis.
FSS: 15.75 (+0.09), UTX: 121.25 (+1.66), DHR: 86.81 (+0.21)
Supercompetitors: Transforming the Rationale for M&A
PRWeb - Tue Feb 03, 8:02AM CST
Supercompetitors such as P&G, Amazon and Danaher have changed the very dynamics of their industries through innovation. Now, their approach to deal making is redefining the rationale for successful mergers and acquisitions.
DHR: 86.81 (+0.21)
Pitney Bowes Earnings In-Line on Digital Commerce Business - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 8:34AM CST
Pitney Bowes Inc. (PBI) reported fourth-quarter 2014 adjusted earnings per share from continuing operations of 51 cents, which came in line with both the Zacks Consensus Estimate as well as the year-ago quarter figure.
PBI: 22.96 (+0.18), FSS: 15.75 (+0.09), DHR: 86.81 (+0.21)
5 Key Takeaways From Danaher Corporation's Earnings Report
Lee Samaha, The Motley Fool - Motley Fool - Sun Feb 01, 8:47AM CST
It's hard not to like diversified industrial Danaher Corporation . Its management tends to underpromise and overdeliver on earnings, which is usually a good thing for investors. Meanwhile, its model of reinvesting cash flow to...
DHR: 86.81 (+0.21)
Analysis of the Western European Immunochemistry Market to 2021
M2 - Sat Jan 31, 12:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/vkwzpf/analysis_of_the) has announced the addition of the "Analysis of the Western European Immunochemistry Market " report to their offering. Acquisitions and partnerships have been the talk of the market. This study analyses how the immunochemistry market will change in light of increasing demand for integrated immunochemistry analysers and assays as consolidation occurs across Western Europe. The research includes a market overview, market engineering measurements, revenue forecasts, company profiling, and key trends for the immunochemistry market and its segments: immunoassay, clinical chemistry, and integrated analysers. Regional analyses are segmented by the United Kingdom, Germany, France, Italy, Spain, Benelux, and Scandinavia. The study period is 2011-2021 with a base year of 2014. Key Questions This Study Will Answer - What are the key factors driving the market and the barriers that need to be resolved? - What is the current market scenario? How much growth is expected? - Which are the major market segments and what are the important trends? - Which are the key market participants involved, and where do they stand? - What are the key application areas that will expand the horizon, and how will they impact the market in the future? - What is the future of the market in Western Europe, and what should participants do to succeed? Key Topics Covered: 1. Executive Summary 2. Market Overview 3. Competitive Playbook 4. Drivers, Restraints, and Trends - Total Immunochemistry Market 5. Forecast and Trends - Total Immunochemistry Market 6. Competitive Environment 7. Immunoassay Segment Analysis 8. Clinical Chemistry Segment Analysis 9. Integrated Analysers Segment Analysis 10. The United Kingdom Analysis 11. Germany Analysis 12. France Analysis 13. Italy Analysis 14. Spain Analysis 15. Benelux Analysis 16. Scandinavia Analysis 17. Key Company Profiles 18. The Last Word 19. Appendix Companies Mentioned - Roche Diagnostics - Siemens Healthcare Diagnostics - Abbott Diagnostics - Ortho Clinical Diagnostics - Thermo Fisher Scientific - Beckman Coulter (Danaher Group) For more information visit http://www.researchandmarkets.com/research/vk...sis_of_the
DHR: 86.81 (+0.21)
Protein Characterization and Identification Market by Instruments, Consumables & Services, Application, & by End Users - Global Forecast to 2019
M2 - Fri Jan 30, 11:42PM CST
Research and Markets (http://www.researchandmarkets.com/research/8mr9p9/protein) has announced the addition of the "Protein Characterization and Identification Market by Instruments, Consumables & Services, Application, & by End Users - Global Forecast to 2019" report to their offering. The global protein characterization and identification market was valued at $1.56 billion in 2014, and is expected to grow at a CAGR of 10.63% to reach $2.6 billion in 2019 The marketing automation software is a sales and marketing tool that helps the company to nurture leads with their likes and dislikes and turn the customers into delighted customers. The software understands the leads behaviour and on that behaviour do scoring and converting into quality leads to the sales team. The software broadly focuses on range of automation and analytic tool for sales and marketing activities through multiple online channels. The major factors that is driving the Marketing Automation Software market is the need of marketing accountability, third-party application ecosystem, and growth in multiple online channels is enhancing the market globally. These drivers are creating demand of the software across various verticals. The major factors which are restricting the growth of Marketing Automation Software market are open source solution, technology shift, and data privacy. Furthermore there are even few challenges like providing customer specific solution to every organisation. There are various assumptions that have been taken into consideration for market sizing and forecasting exercise. Few of global assumptions include political, economic, social, technological and economic factors. For instance, economic factor such as exchange rates are expected to have a moderate rating of impact on this market. Therefore, dollar fluctuations are not expected to seriously affect the forecasts in the emerging APAC and LA regions. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Protein Characterization and Identification Market, By Application 8 Protein Characterization and Identification Market, By Product 9 Protein Characterization and Identification Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Bruker Corporation - Danaher Corporation - General Electric - Perkinelmer, Inc. - Shimadzu Corporation - Sigma-Aldrich Corporation - Thermo Fisher Scientific - Waters Corporation For more information visit http://www.researchandmarkets.com/research/8mr9p9/protein
A: 40.15 (+0.13), SIAL: 138.20 (+0.07), DHR: 86.81 (+0.21), WAT: 119.86 (+0.71)
Clinical Chemistry Analyzer Market by Product, Test Type, End User - Global Forecast to 2019
M2 - Fri Jan 30, 11:40PM CST
Research and Markets (http://www.researchandmarkets.com/research/grpwmh/clinical) has announced the addition of the "Clinical Chemistry Analyzer Market by Product, Test Type, End User - Global Forecast to 2019" report to their offering. Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals), End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019 The global clinical chemistry analyzers market report segments this market on the basis of products, test, end users and regions. The clinical chemistry analyzers segment is further divided into four subsegments, Small (400-800 Test/H), Medium (800-1,200 Tests/H), Large (1,200-2,000 Tests/H), and Very large (2,000 Tests/H). The reagent segment is categorized into calibrators, controls, standards and other reagents. The test segments included in this report are basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile/kidney function panel, thyroid function panel, specialty chemical tests. A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global clinical chemistry analyzers market and its subsegments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of the market players. Estimates of their clinical chemistry analyzers segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in the growth rates. The key drivers for this market are rise in number of lifestyle diseases; automation of laboratories will aid the growth of this market. Increasing awareness for preventative care, increase in aging population, increase in reagent rental agreements and laboratory automation will drive the demand for clinical chemistry analyzers products. Growth in the clinical chemistry market will drive the growth of the clinical chemistry analyzers market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Clinical Chemistry Analyzers Market, By Product 8 Clinical Chemistry Analyzers Market, By Test 9 Clinical Chemistry Analyzers Market, By End Users 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Abbott Laboratories - Danaher Corporation - Elitech Group - F. Hoffmann-La Roche Ltd. - Horiba, Ltd. - Johnson & Johnson - Mindray Medical International Limited - Randox Laboratories Ltd. - Siemens AG - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/grpwmh/clinical
JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), DHR: 86.81 (+0.21), MR: 27.19 (+0.15)
Cell Expansion Market by Product , Cell Type, Application, End User - Forecast to 2019
M2 - Fri Jan 30, 11:35PM CST
Research and Markets (http://www.researchandmarkets.com/research/br25h6/cell_expansion) has announced the addition of the "Cell Expansion Market by Product , Cell Type, Application, End User - Forecast to 2019" report to their offering. The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The cell expansion market is segmented on the basis of product, cell type, application, end-user, and geography. On the basis of product, the cell expansion market is segmented into consumables and instruments. In 2014, the consumables segment is expected to account for the largest share of the global cell expansion market, by product. The high share can be attributed to the extensive requirement of media in cell expansion process. The consumables market is further divided into reagents, media and serum, and disposables. The instrument market is segmented into automated cell expansion systems, bioreactors and supporting equipment. Supporting equipment include centrifuges, flow cytometers, filtration systems, incubators, microscopes, laminar air flow cabinets and others. The others segment includes strainers, water baths, vortex mixers, pipettes, and cell counters. The bioreactors segment is further categorized into micro carrier bioreactor and perfusion or hollow fiber bioreactors. The cell expansion market by cell type is bifurcated into human cells and animal cells. The human cell market is further sub segmented into stem cells and differentiated cells. The stem cell expansion market is poised to witness the highest growth in the cell expansion market, by cell type, owing to the increasing government funding of stem cell research and investments by companies to boost the research in cancer. The cell expansion market, by application is classified into cancer and stem cell research, regenerative medicine, biotechnology and biopharmaceutical and clinical diagnostics; while the cell expansion market, by end-user is divided into research institutes, hospitals and diagnostic laboratories, cell banks, and biotechnology and biopharmaceutical companies. The global cell expansion market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America will continue to lead the global cell expansion market in the forecast period, followed by Europe. Over the next five years, the growth of the global cell expansion market in the Asian region is likely to be centered on China, Japan, and India. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Cell Expansion Market, By Product 8 Cell Expansion Market, By Cell Type 9 Cell Expansion Market, By Application 10 Cell Expansion Market, By End User 11 Cell Expansion Market, By Geography 12 Competitive Landscape 13 Company Profiles - Beckman Coulter (Subsidiary of Danaher Corporation) - Becton Dickinson and Company - Corning Incorporated - Ge Healthcare (A Fully Owned Subsidiary of General Electric Company) - Merck Millipore (A Segment of Merck Kgaa) - Miltenyi Biotec - Sigma-Aldrich Corporation - Stemcell Technologies - Terumo BCT (A Subsidiary of Terumo Corporation) - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/br..._expansion
GE: 25.15 (+0.26), SIAL: 138.20 (+0.07), MRK: 58.81 (-0.07), DHR: 86.81 (+0.21)
Rexnord Corporation Names George Moore to Its Board of Directors
Business Wire - Fri Feb 13, 8:35AM CST
Rexnord Corporation (NYSE: RXN) today announced that George C. Moore will join the Company's Board of Directors effective February 12, 2015.
RXN: 27.85 (+0.08), DHR: 86.81 (+0.21)
Danaher To Present At Barclays Industrial Select Conference
PR Newswire - Thu Feb 12, 3:45PM CST
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Barclays Industrial Select Conference in Miami, Florida on Thursday, February 19, 2015 at 8:55 a.m. ET. The audio will be simultaneously webcast and will be archived on www.danaher.com.
DHR: 86.81 (+0.21)
Leading Vaporization Company Ploom Brings on Two Senior Executives
Business Wire - Wed Feb 11, 10:00AM CST
Ploom, a San Francisco-based leader in vaporization delivery systems, announced today that it has added two senior executives to its team. Timothy Danaher was named VP of Finance and Scott Dunlap was appointed Chief Marketing Officer. Reporting to Founder and CEO James Monsees, Mr. Danaher will play a critical role in developing and executing the overall business and financial strategy of Ploom to maximize sales growth and profitability. Mr. Dunlap will be responsible for crafting the strategic marketing vision and plan behind all of Ploom's future, innovative, first-to-market products. He will also report to the CEO, James Monsees.
DHR: 86.81 (+0.21)
General Purpose Test Equipment Market in China 2015-2019 with Agilent Technologies, Anritsu, Danaher, Fluke, Rohde & Schwarz & Tektronix Dominating
M2 - Wed Feb 11, 5:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/n2w98n/general_purpose) has announced the addition of the "General Purpose Test Equipment Market in China 2015-2019" report to their offering. The analysts forecast the General Purpose Test Equipment market in China to grow at a CAGR of 9.89 percent over the period 2015-2019. This report covers the present scenario and the growth prospects of the General Purpose Test Equipment market in China during the period 2015-2019. To calculate the market size and vendor share, the report considers revenue generated from the sales of general purpose test equipment and its services in China. General purpose test equipment includes different testing and measuring equipment such as oscilloscopes, spectrum analyzers, signal generators, multimeters, arbitrary waveform generators, logic analyzers, spectrum analyzers, power meters, electronic counters, and VXI/PXI-based instruments. Industries such as Communications, Aerospace and Defense, Mechanical, and Electronics uses this equipment for testing their design prototypes or finished products to check uniformity with the required specifications and ascertain whether the devices are fulfilling their intended purpose. Key Vendors - Agilent Technologies - Anritsu - Danaher - Fluke - Rohde & Schwarz - Tektronix Other Prominent Vendors - Adlink Technology - Aeroflex - Ametek - Giga-tronics - National Instruments - Rigol Technologies - Teledyne LeCroy - Teradyne - Yokagawa Electric Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product - Market Segmentation by Technology Type - Market Segmentation by End-users - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/n2...al_purpose
AME: 51.41 (+0.80), A: 40.15 (+0.13), DHR: 86.81 (+0.21), TER: 19.43 (+0.04), NATI: 31.20 (+0.31)
Two Executives Join ediscovery Leadership Team at Disco
Business Wire - Tue Feb 10, 6:30AM CST
Legal technology company CS Disco Inc., based in Houston, Texas, has announced two executives have joined the Disco ediscovery team, including a vice president of sales and a vice president of engineering and product development.
DHR: 86.81 (+0.21)
Macrocure Hires Mark Page as Chief Financial Officer
GlobeNewswire - Mon Feb 09, 3:04AM CST
Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, today announced that Mark Page, a Managing Director at Credit Suisse in New York, will join Macrocure as Chief Financial Officer effective February 10, 2015.
JNJ: 99.62 (+1.18), MCUR: 11.19 (-0.65), DHR: 86.81 (+0.21)
Industrial Conglomerates Equities Technical Updates - General Electric, 3M, Danaher, Koninklijke Philips, and Roper Industries
PR Newswire - Fri Feb 06, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: General Electric Company (NYSE: GE), 3M Company (NYSE: MMM), Danaher Corporation (NYSE: DHR), Koninklijke Philips N.V. (NYSE: PHG), and Roper Industries Inc. (NYSE: ROP). Free research report on General Electric can be accessed at http://get.Investor-Edge.com/pdf/?c=General%2...5&s=GE. On Thursday, February 05, 2015, the NASDAQ Composite ended at 4,765.10, up 1.03%, the Dow Jones Industrial Average advanced 1.20%, to finish the day at 17,884.88, and the S&P 500 closed at 2,062.52, up 1.03%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Industrials Sector Index ended the day at 483.79, up 0.97%, with the index also advancing 1.96% in the last one month. Register for your complimentary reports at the links given below.
ROP: 166.23 (+1.16), MMM: 165.94 (+0.03), GE: 25.15 (+0.26), PHG: 28.93 (-0.07), DHR: 86.81 (+0.21)
3 Stocks Boosting The Industrial Goods Sector Higher
at The Street - Thu Feb 05, 11:03AM CST
TheStreet highlights 3 stocks pushing the industrial goods sector higher today.
HON: 104.38 (+0.88), UTX: 121.25 (+1.66), DHR: 86.81 (+0.21)
Macquarie (MIC) to Acquire Bayonne Energy for $720M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 5:11PM CST
Macquarie Infrastructure Company (MIC) recently entered into an agreement to acquire Bayonne Energy Center (BEC) for approximately $720 million.
MIC: 76.58 (+1.26), FSS: 15.75 (+0.09), DHR: 86.81 (+0.21)
GE Secures General Dynamics Orders Worth $100M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 4:08PM CST
General Electric's Intelligent Platforms, a part of General Electric Company (GE), recently secured orders worth approximately $100 million from General Dynamics UK.
GD: 137.61 (-0.54), GE: 25.15 (+0.26), FSS: 15.75 (+0.09), DHR: 86.81 (+0.21)
SmarTrend Watching for Potential Pullback in Shares of Danaher After 1.53% Gain
Comtex SmarTrend(R) - Tue Feb 03, 4:48PM CST
Danaher (NYSE
HR) traded in a range yesterday that spanned from a low of $84.27 to a high of $85.13. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $83.98 on volume of 4.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. DHR: 86.81 (+0.21)
Danaher Rises 1.53% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Feb 03, 4:47PM CST
Danaher (NYSE
HR) traded in a range yesterday that spanned from a low of $84.27 to a high of $85.13. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $83.98 on volume of 4.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. DHR: 86.81 (+0.21)
United Technologies (UTX) Hikes Quarterly Dividend by 8.5% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 4:00PM CST
United Technologies Corporation (UTX) recently announced an 8.5% year-over-year hike in its quarterly dividend payout to 64 cents per share or $2.56 on an annualized basis.
FSS: 15.75 (+0.09), UTX: 121.25 (+1.66), DHR: 86.81 (+0.21)
Supercompetitors: Transforming the Rationale for M&A
PRWeb - Tue Feb 03, 8:02AM CST
Supercompetitors such as P&G, Amazon and Danaher have changed the very dynamics of their industries through innovation. Now, their approach to deal making is redefining the rationale for successful mergers and acquisitions.
DHR: 86.81 (+0.21)
Pitney Bowes Earnings In-Line on Digital Commerce Business - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 8:34AM CST
Pitney Bowes Inc. (PBI) reported fourth-quarter 2014 adjusted earnings per share from continuing operations of 51 cents, which came in line with both the Zacks Consensus Estimate as well as the year-ago quarter figure.
PBI: 22.96 (+0.18), FSS: 15.75 (+0.09), DHR: 86.81 (+0.21)
5 Key Takeaways From Danaher Corporation's Earnings Report
Lee Samaha, The Motley Fool - Motley Fool - Sun Feb 01, 8:47AM CST
It's hard not to like diversified industrial Danaher Corporation . Its management tends to underpromise and overdeliver on earnings, which is usually a good thing for investors. Meanwhile, its model of reinvesting cash flow to...
DHR: 86.81 (+0.21)
Analysis of the Western European Immunochemistry Market to 2021
M2 - Sat Jan 31, 12:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/vkwzpf/analysis_of_the) has announced the addition of the "Analysis of the Western European Immunochemistry Market " report to their offering. Acquisitions and partnerships have been the talk of the market. This study analyses how the immunochemistry market will change in light of increasing demand for integrated immunochemistry analysers and assays as consolidation occurs across Western Europe. The research includes a market overview, market engineering measurements, revenue forecasts, company profiling, and key trends for the immunochemistry market and its segments: immunoassay, clinical chemistry, and integrated analysers. Regional analyses are segmented by the United Kingdom, Germany, France, Italy, Spain, Benelux, and Scandinavia. The study period is 2011-2021 with a base year of 2014. Key Questions This Study Will Answer - What are the key factors driving the market and the barriers that need to be resolved? - What is the current market scenario? How much growth is expected? - Which are the major market segments and what are the important trends? - Which are the key market participants involved, and where do they stand? - What are the key application areas that will expand the horizon, and how will they impact the market in the future? - What is the future of the market in Western Europe, and what should participants do to succeed? Key Topics Covered: 1. Executive Summary 2. Market Overview 3. Competitive Playbook 4. Drivers, Restraints, and Trends - Total Immunochemistry Market 5. Forecast and Trends - Total Immunochemistry Market 6. Competitive Environment 7. Immunoassay Segment Analysis 8. Clinical Chemistry Segment Analysis 9. Integrated Analysers Segment Analysis 10. The United Kingdom Analysis 11. Germany Analysis 12. France Analysis 13. Italy Analysis 14. Spain Analysis 15. Benelux Analysis 16. Scandinavia Analysis 17. Key Company Profiles 18. The Last Word 19. Appendix Companies Mentioned - Roche Diagnostics - Siemens Healthcare Diagnostics - Abbott Diagnostics - Ortho Clinical Diagnostics - Thermo Fisher Scientific - Beckman Coulter (Danaher Group) For more information visit http://www.researchandmarkets.com/research/vk...sis_of_the
DHR: 86.81 (+0.21)
Protein Characterization and Identification Market by Instruments, Consumables & Services, Application, & by End Users - Global Forecast to 2019
M2 - Fri Jan 30, 11:42PM CST
Research and Markets (http://www.researchandmarkets.com/research/8mr9p9/protein) has announced the addition of the "Protein Characterization and Identification Market by Instruments, Consumables & Services, Application, & by End Users - Global Forecast to 2019" report to their offering. The global protein characterization and identification market was valued at $1.56 billion in 2014, and is expected to grow at a CAGR of 10.63% to reach $2.6 billion in 2019 The marketing automation software is a sales and marketing tool that helps the company to nurture leads with their likes and dislikes and turn the customers into delighted customers. The software understands the leads behaviour and on that behaviour do scoring and converting into quality leads to the sales team. The software broadly focuses on range of automation and analytic tool for sales and marketing activities through multiple online channels. The major factors that is driving the Marketing Automation Software market is the need of marketing accountability, third-party application ecosystem, and growth in multiple online channels is enhancing the market globally. These drivers are creating demand of the software across various verticals. The major factors which are restricting the growth of Marketing Automation Software market are open source solution, technology shift, and data privacy. Furthermore there are even few challenges like providing customer specific solution to every organisation. There are various assumptions that have been taken into consideration for market sizing and forecasting exercise. Few of global assumptions include political, economic, social, technological and economic factors. For instance, economic factor such as exchange rates are expected to have a moderate rating of impact on this market. Therefore, dollar fluctuations are not expected to seriously affect the forecasts in the emerging APAC and LA regions. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Protein Characterization and Identification Market, By Application 8 Protein Characterization and Identification Market, By Product 9 Protein Characterization and Identification Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Bruker Corporation - Danaher Corporation - General Electric - Perkinelmer, Inc. - Shimadzu Corporation - Sigma-Aldrich Corporation - Thermo Fisher Scientific - Waters Corporation For more information visit http://www.researchandmarkets.com/research/8mr9p9/protein
A: 40.15 (+0.13), SIAL: 138.20 (+0.07), DHR: 86.81 (+0.21), WAT: 119.86 (+0.71)
Clinical Chemistry Analyzer Market by Product, Test Type, End User - Global Forecast to 2019
M2 - Fri Jan 30, 11:40PM CST
Research and Markets (http://www.researchandmarkets.com/research/grpwmh/clinical) has announced the addition of the "Clinical Chemistry Analyzer Market by Product, Test Type, End User - Global Forecast to 2019" report to their offering. Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals), End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019 The global clinical chemistry analyzers market report segments this market on the basis of products, test, end users and regions. The clinical chemistry analyzers segment is further divided into four subsegments, Small (400-800 Test/H), Medium (800-1,200 Tests/H), Large (1,200-2,000 Tests/H), and Very large (2,000 Tests/H). The reagent segment is categorized into calibrators, controls, standards and other reagents. The test segments included in this report are basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile/kidney function panel, thyroid function panel, specialty chemical tests. A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global clinical chemistry analyzers market and its subsegments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of the market players. Estimates of their clinical chemistry analyzers segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in the growth rates. The key drivers for this market are rise in number of lifestyle diseases; automation of laboratories will aid the growth of this market. Increasing awareness for preventative care, increase in aging population, increase in reagent rental agreements and laboratory automation will drive the demand for clinical chemistry analyzers products. Growth in the clinical chemistry market will drive the growth of the clinical chemistry analyzers market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Clinical Chemistry Analyzers Market, By Product 8 Clinical Chemistry Analyzers Market, By Test 9 Clinical Chemistry Analyzers Market, By End Users 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Abbott Laboratories - Danaher Corporation - Elitech Group - F. Hoffmann-La Roche Ltd. - Horiba, Ltd. - Johnson & Johnson - Mindray Medical International Limited - Randox Laboratories Ltd. - Siemens AG - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/grpwmh/clinical
JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), DHR: 86.81 (+0.21), MR: 27.19 (+0.15)
Cell Expansion Market by Product , Cell Type, Application, End User - Forecast to 2019
M2 - Fri Jan 30, 11:35PM CST
Research and Markets (http://www.researchandmarkets.com/research/br25h6/cell_expansion) has announced the addition of the "Cell Expansion Market by Product , Cell Type, Application, End User - Forecast to 2019" report to their offering. The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The cell expansion market is segmented on the basis of product, cell type, application, end-user, and geography. On the basis of product, the cell expansion market is segmented into consumables and instruments. In 2014, the consumables segment is expected to account for the largest share of the global cell expansion market, by product. The high share can be attributed to the extensive requirement of media in cell expansion process. The consumables market is further divided into reagents, media and serum, and disposables. The instrument market is segmented into automated cell expansion systems, bioreactors and supporting equipment. Supporting equipment include centrifuges, flow cytometers, filtration systems, incubators, microscopes, laminar air flow cabinets and others. The others segment includes strainers, water baths, vortex mixers, pipettes, and cell counters. The bioreactors segment is further categorized into micro carrier bioreactor and perfusion or hollow fiber bioreactors. The cell expansion market by cell type is bifurcated into human cells and animal cells. The human cell market is further sub segmented into stem cells and differentiated cells. The stem cell expansion market is poised to witness the highest growth in the cell expansion market, by cell type, owing to the increasing government funding of stem cell research and investments by companies to boost the research in cancer. The cell expansion market, by application is classified into cancer and stem cell research, regenerative medicine, biotechnology and biopharmaceutical and clinical diagnostics; while the cell expansion market, by end-user is divided into research institutes, hospitals and diagnostic laboratories, cell banks, and biotechnology and biopharmaceutical companies. The global cell expansion market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America will continue to lead the global cell expansion market in the forecast period, followed by Europe. Over the next five years, the growth of the global cell expansion market in the Asian region is likely to be centered on China, Japan, and India. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Cell Expansion Market, By Product 8 Cell Expansion Market, By Cell Type 9 Cell Expansion Market, By Application 10 Cell Expansion Market, By End User 11 Cell Expansion Market, By Geography 12 Competitive Landscape 13 Company Profiles - Beckman Coulter (Subsidiary of Danaher Corporation) - Becton Dickinson and Company - Corning Incorporated - Ge Healthcare (A Fully Owned Subsidiary of General Electric Company) - Merck Millipore (A Segment of Merck Kgaa) - Miltenyi Biotec - Sigma-Aldrich Corporation - Stemcell Technologies - Terumo BCT (A Subsidiary of Terumo Corporation) - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/br..._expansion
GE: 25.15 (+0.26), SIAL: 138.20 (+0.07), MRK: 58.81 (-0.07), DHR: 86.81 (+0.21)
